Mitsubishi Tanabe has agreed to acquire NeuroDerm, a clinical stage pharmaceutical company, for $1.1 billion.
The creator of OmniRat, the first human monoclonal antibody technology based on rats, outlined the success story of the project yesterday at the 2017 BIO International Convention.
Merck has been granted its first CRISPR technology patent by the Australian Patent Office.
The World Intellectual Property Organization’s Re:Search has launched a new five-year guide to its activities in the fight against neglected tropical diseases, malaria and tuberculosis.
The World Health Organization will launch a pilot project for biosimilars to make costly cancer treatments more widely available in low and middle income countries.
India-based Initiative for Medicines, Access & Knowledge has filed four patent challenges against patents covering hepatitis C drugs in a bid to ensure access to affordable treatment.
Global intellectual property strategy will be the chief area of focus for IP counsel in the life sciences arena in 2017.
The World Trade Organization has amended its intellectual property rules to make it easier for poor countries to access affordable medicines.
A report released by the Australian government has said Australia's extension of term scheme for patents in the pharmaceutical industry "has had little effect" on investment and innovation.
Phylogica, an Australian drug discovery company, has extended its research collaboration and licensing agreement with Genentech to discover novel antibiotics.